{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:37Z","timestamp":1792804177968,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":1113,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.rmed.2010.03.017","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:51:44Z","timestamp":1276059104000},"page":"S45-S58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"S1","title":["Lymphangioleiomyomatosis (LAM): Molecular insights lead to targeted therapies"],"prefix":"10.1016","volume":"104","author":[{"given":"Connie G.","family":"Glasgow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Steagall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Taveira-DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Pacheco-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souheil","family":"El-Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Pt 1","key":"10.1016\/j.rmed.2010.03.017_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1378\/chest.115.4.1041","article-title":"Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis","volume":"115","author":"Chu","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","article-title":"Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d\u2019Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP)","volume":"78","author":"Urban","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/thorax.55.12.1052","article-title":"Clinical experience of lymphangioleiomyomatosis in the UK","volume":"55","author":"Johnson","year":"2000","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/107327480601300405","article-title":"Lymphangioleiomyomatosis","volume":"13","author":"Taveira-DaSilva","year":"2006","journal-title":"Cancer Control"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2004.023283","article-title":"Survival and disease progression in UK patients with lymphangioleiomyomatosis","volume":"59","author":"Johnson","year":"2004","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/ajrccm.164.6.2102125","article-title":"Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis","volume":"164","author":"Taveira-DaSilva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiology.214.2.r00fe41441","article-title":"Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests","volume":"214","author":"Avila","year":"2000","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nippon Med Sch"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet."},{"issue":"11","key":"10.1016\/j.rmed.2010.03.017_bib12","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","article-title":"Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis","volume":"47","author":"Sato","year":"2002","journal-title":"J Hum Genet"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/hupa.2000.18500","article-title":"Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases","volume":"31","author":"Matsui","year":"2000","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-200101000-00004","article-title":"Lymphangioleiomyomatosis","volume":"321","author":"Kelly","year":"2001","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.96.09030402","article-title":"Extrathoracic angiomyolipomas in lymphangioleiomyomatosis","volume":"9","author":"Maziak","year":"1996","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.rmed.2010.03.017_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.5858\/2000-124-1642-HOTIPI","article-title":"Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rmed.2010.03.017_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rmed.2010.03.017_bib20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/hmg\/3.suppl_1.1477","article-title":"The molecular genetics of tuberous sclerosis","volume":"3 Spec No","author":"Sampson","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/ajrccm.164.4.2011025","article-title":"Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis","volume":"164","author":"Franz","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/75.6.591","article-title":"High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex","volume":"75","author":"Costello","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"50","key":"10.1016\/j.rmed.2010.03.017_bib26","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000478-200104000-00007","article-title":"Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score","volume":"25","author":"Matsui","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2231010315","article-title":"Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis","volume":"223","author":"Avila","year":"2002","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1378\/chest.109.1.131","article-title":"Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis","volume":"109","author":"Crausman","year":"1996","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1378\/chest.125.1.135","article-title":"Diffuse cystic lung diseases: correlation between radiologic and functional status","volume":"125","author":"Paciocco","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2214\/AJR.07.3334","article-title":"Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis","volume":"192","author":"Schmithorst","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib33","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200206-593OC","article-title":"Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis","volume":"168","author":"Taveira-DaSilva","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 Pt 1","key":"10.1016\/j.rmed.2010.03.017_bib34","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/ajrccm.153.4.8616568","article-title":"Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity","volume":"153","author":"Crausman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1378\/chest.07-1205","article-title":"Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study","volume":"132","author":"Taveira-DaSilva","year":"2007","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1164\/rccm.200405-578OC","article-title":"Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia","volume":"171","author":"Eaton","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.rmed.2003.11.013","article-title":"Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis","volume":"98","author":"Lazor","year":"2004","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","article-title":"The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors","volume":"12","author":"Hayashida","year":"2007","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000478-198909000-00011","article-title":"Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis","volume":"13","author":"Colley","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ajcp\/93.5.609","article-title":"Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study","volume":"93","author":"Berger","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/96.4.529","article-title":"Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung","volume":"96","author":"Ohori","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib43","first-page":"277","article-title":"Pulmonary lymphangioleiomyomatosis complicated by pregnancy","volume":"87","author":"Yockey","year":"1986","journal-title":"Kans Med"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0020-7292(95)02619-3","article-title":"Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax","volume":"52","author":"Brunelli","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.91.5.782","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens","volume":"91","author":"Shen","year":"1987","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thorax.57.12.1085","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment","volume":"57","author":"Yano","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/154099903321154176","article-title":"Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease","volume":"12","author":"Oberstein","year":"2003","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/thx.49.9.910","article-title":"Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study","volume":"49","author":"Wahedna","year":"1994","journal-title":"Thorax"},{"issue":"18","key":"10.1016\/j.rmed.2010.03.017_bib49","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM199011013231807","article-title":"Clinical course in 32 patients","volume":"323","author":"Taylor","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/ajrccm\/143.1.174","article-title":"Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis","volume":"143","author":"Rossi","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib51","first-page":"300","article-title":"Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist","volume":"13","author":"Desurmont","year":"1996","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmed.2010.03.017_bib52","first-page":"A701","article-title":"Evaluation of functional pulmonary response to gonadotrophin releasing hormone agonist (goserelin) in the treatment of lymphangioleiomyomatosis","volume":"165","author":"Medeiros","year":"2002","journal-title":"Am J Respir Crit Care Medicine"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib53","first-page":"377","article-title":"Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone-releasing hormone analogues","volume":"2","author":"de la Fuente","year":"1993","journal-title":"Eur J Med"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.07-2277","article-title":"Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis","volume":"133","author":"Harari","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2010.03.017_bib55","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib56","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2007-1283","article-title":"Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness","volume":"93","author":"Glassberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/ERC-08-0123","article-title":"Analysis of the oestrogen response in an angiomyolipoma derived xenograft model","volume":"16","author":"Clements","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccm.2006.01.005","article-title":"Pleural disease in lymphangioleiomyomatosis","volume":"27","author":"Almoosa","year":"2006","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib59","doi-asserted-by":"crossref","first-page":"L800","DOI":"10.1152\/ajplung.00176.2007","article-title":"Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis","volume":"293","author":"Steagall","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib60","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1152\/japplphysiol.01087.2004","article-title":"Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces","volume":"98","author":"Suki","year":"2005","journal-title":"J Appl Physiol"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib61","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0046-8177(06)80039-0","article-title":"Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis","volume":"21","author":"Fukuda","year":"1990","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1148\/radiology.216.1.r00jl42147","article-title":"Lymphangioleiomyomatosis: abdominopelvic CT and US findings","volume":"216","author":"Avila","year":"2000","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.2212001448","article-title":"Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas","volume":"221","author":"Avila","year":"2001","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2214\/ajr.184.2.01840459","article-title":"Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size","volume":"184","author":"Avila","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.rmed.2010.03.017_bib67","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","article-title":"Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development","volume":"92","author":"Kaipainen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib68","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1242\/dev.122.12.3829","article-title":"VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development","volume":"122","author":"Kukk","year":"1996","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.00005.2002","article-title":"Vascular growth factors and lymphangiogenesis","volume":"82","author":"Jussila","year":"2002","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.rmed.2010.03.017_bib71","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.pas.0000126859.70814.6d","article-title":"Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis","volume":"28","author":"Kumasaka","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib72","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/01.pas.0000172192.25295.45","article-title":"Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis","volume":"29","author":"Kumasaka","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/lrb.2006.4.143","article-title":"Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis","volume":"4","author":"Seyama","year":"2006","journal-title":"Lymphat Res Biol"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib74","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.08-1160","article-title":"Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement","volume":"135","author":"Glasgow","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJMc0707517","article-title":"Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis","volume":"358","author":"Young","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib76","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1046\/j.1432-1327.2000.01257.x","article-title":"Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3","volume":"267","author":"Achen","year":"2000","journal-title":"Eur J Biochem"},{"issue":"3\u20134","key":"10.1016\/j.rmed.2010.03.017_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/lrb.2008.1015","article-title":"From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy","volume":"6","author":"Stacker","year":"2008","journal-title":"Lymphat Res Biol"},{"issue":"15 Pt 2","key":"10.1016\/j.rmed.2010.03.017_bib78","doi-asserted-by":"crossref","first-page":"s4617","DOI":"10.1158\/1078-0432.CCR-07-0539","article-title":"Vascular endothelial growth factor receptor tyrosine kinase inhibitors vandetanib (ZD6474) and AZD2171 in lung cancer","volume":"13","author":"Hanrahan","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib79","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/gcc.10252","article-title":"Metastasis of benign tumor cells in tuberous sclerosis complex","volume":"38","author":"Henske","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/er.2006-0027","article-title":"Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis","volume":"28","author":"Langley","year":"2007","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00262-003-0494-4","article-title":"CD44v6: a target for antibody-based cancer therapy","volume":"53","author":"Heider","year":"2004","journal-title":"Cancer Immunol Immunother"},{"issue":"13","key":"10.1016\/j.rmed.2010.03.017_bib83","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1101\/gad.1430906","article-title":"A positive feedback loop couples Ras activation and CD44 alternative splicing","volume":"20","author":"Cheng","year":"2006","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/MCB.26.1.362-370.2006","article-title":"Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion","volume":"26","author":"Cheng","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"6916","key":"10.1016\/j.rmed.2010.03.017_bib85","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature01153","article-title":"Signal-dependent regulation of splicing via phosphorylation of Sam68","volume":"420","author":"Matter","year":"2002","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.rmed.2010.03.017_bib86","doi-asserted-by":"crossref","first-page":"13916","DOI":"10.1016\/S0021-9258(18)68331-0","article-title":"Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor","volume":"263","author":"Noda","year":"1988","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/abbi.1997.0151","article-title":"Stimulation of osteopontin mRNA expression in HL-60 cells is independent of differentiation","volume":"343","author":"Atkins","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib88","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1210\/endo.138.10.5431","article-title":"Progesterone regulates osteopontin expression in human trophoblasts: a model of paracrine control in the placenta?","volume":"138","author":"Omigbodun","year":"1997","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib89","first-page":"219","article-title":"CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine\u2013glycine\u2013aspartic acid, thereby stimulating cell motility and chemotaxis","volume":"59","author":"Katagiri","year":"1999","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib90","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/carcin\/bgg139","article-title":"Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells","volume":"24","author":"Gao","year":"2003","journal-title":"Carcinogenesis"},{"issue":"21","key":"10.1016\/j.rmed.2010.03.017_bib91","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriguez","year":"2007","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib92","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1349-7006.2004.tb03179.x","article-title":"Mechanism and biological significance of CD44 cleavage","volume":"95","author":"Nagano","year":"2004","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib93","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/jid.2008.323","article-title":"ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells","volume":"129","author":"Anderegg","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(91)90403-L","article-title":"A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells","volume":"65","author":"Gunthert","year":"1991","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.rmed.2010.03.017_bib95","first-page":"3719","article-title":"Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment","volume":"58","author":"Reeder","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D","article-title":"Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells","volume":"91","author":"Harada","year":"2001","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib97","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nature Med"},{"issue":"6824","key":"10.1016\/j.rmed.2010.03.017_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib99","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","article-title":"Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene","volume":"182","author":"Pacheco-Rodriguez","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.20042469","article-title":"MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development","volume":"202","author":"Li","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib101","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/138161209787582165","article-title":"Chemokine receptors as targets for cancer therapy","volume":"15","author":"Wu","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1517\/14728222.7.1.35","article-title":"Targeting monocyte chemoattractant protein-1 signalling in disease","volume":"7","author":"Dawson","year":"2003","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005344-200109000-00008","article-title":"Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice","volume":"38","author":"Dol","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.rmed.2010.03.017_bib104","series-title":"Zinc metalloproteases in health and disease","first-page":"153","article-title":"Matrix metalloproteinases","author":"Nagase","year":"1996"},{"issue":"Suppl","key":"10.1016\/j.rmed.2010.03.017_bib105","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib106","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.bjc.6601725","article-title":"Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera","volume":"90","author":"La Rocca","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib107","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/030089160609200211","article-title":"Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer","volume":"92","author":"Koc","year":"2006","journal-title":"Tumori"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib108","first-page":"813","article-title":"Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck","volume":"127","author":"O-Charoenrat","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.rmed.2010.03.017_bib109","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1245\/ASO.2004.01.013","article-title":"The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer","volume":"11","author":"Tamura","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.rmed.2010.03.017_bib110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ijc.11436","article-title":"Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients","volume":"107","author":"Tutton","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib111","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2559.2007.02615.x","article-title":"The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma","volume":"50","author":"Mylona","year":"2007","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib112","first-page":"1395","article-title":"Increased incidence of matrix metalloproteinases in urine of cancer patients","volume":"58","author":"Moses","year":"1998","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib113","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00686191","article-title":"The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism","volume":"36","author":"Gilbertson-Beadling","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/lrb.2006.4.83","article-title":"Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix","volume":"4","author":"Ji","year":"2006","journal-title":"Lymphat Res Biol"},{"issue":"24","key":"10.1016\/j.rmed.2010.03.017_bib115","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs","volume":"354","author":"Moses","year":"2006","journal-title":"N Engl J Med"},{"issue":"40","key":"10.1016\/j.rmed.2010.03.017_bib116","doi-asserted-by":"crossref","first-page":"37258","DOI":"10.1074\/jbc.M106089200","article-title":"The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00726-008-0066-1","article-title":"Tuberin, p27 and MTOR in different cells","volume":"36","author":"Burgstaller","year":"2009","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib118","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","article-title":"MTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation","volume":"30","author":"Hong","year":"2008","journal-title":"Mol Cell"},{"issue":"16","key":"10.1016\/j.rmed.2010.03.017_bib119","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1158\/0008-5472.CAN-07-5756","article-title":"AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27","volume":"68","author":"Short","year":"2008","journal-title":"Cancer Res"},{"issue":"47","key":"10.1016\/j.rmed.2010.03.017_bib120","doi-asserted-by":"crossref","first-page":"48707","DOI":"10.1074\/jbc.M405528200","article-title":"Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2","volume":"279","author":"Rosner","year":"2004","journal-title":"J Biol Chem"},{"issue":"35","key":"10.1016\/j.rmed.2010.03.017_bib121","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/sj.onc.1204627","article-title":"Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression","volume":"20","author":"Soucek","year":"2001","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib122","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ceb.2009.01.024","article-title":"MTOR and the control of whole body metabolism","volume":"21","author":"Polak","year":"2009","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol Cell"},{"issue":"14","key":"10.1016\/j.rmed.2010.03.017_bib125","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of MTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib127","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits MTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.rmed.2010.03.017_bib128","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood-2006-06-030833","article-title":"Rapamycin derivatives reduce MTORC2 signaling and inhibit AKT activation in AML","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.rmed.2010.03.017_bib129","first-page":"4766","article-title":"Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles","volume":"58","author":"Plank","year":"1998","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","article-title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products","volume":"7","author":"van Slegtenhorst","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"50","key":"10.1016\/j.rmed.2010.03.017_bib131","doi-asserted-by":"crossref","first-page":"35647","DOI":"10.1074\/jbc.274.50.35647","article-title":"Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin","volume":"274","author":"Nellist","year":"1999","journal-title":"J Biol Chem"},{"issue":"5327","key":"10.1016\/j.rmed.2010.03.017_bib132","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00726-004-0119-z","article-title":"Proteins interacting with the tuberous sclerosis gene products","volume":"27","author":"Rosner","year":"2004","journal-title":"Amino Acids"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamb","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib135","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1038\/35010506","article-title":"A new twist for the tumour suppressor hamartin","volume":"2","author":"Fukuhara","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"7","key":"10.1016\/j.rmed.2010.03.017_bib136","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"The European Chromosome 16 tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"issue":"35","key":"10.1016\/j.rmed.2010.03.017_bib137","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.C300226200","article-title":"Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner","volume":"278","author":"Castro","year":"2003","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.rmed.2010.03.017_bib138","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control MTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr Biol"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib139","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"54","key":"10.1016\/j.rmed.2010.03.017_bib140","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib141","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by MTOR and its downstream targets S6K1 and 4EBP1\/eIF4E","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib142","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses MTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib143","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/j.rmed.2010.03.017_bib144","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ncb847","article-title":"Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling","volume":"4","author":"Gao","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"34","key":"10.1016\/j.rmed.2010.03.017_bib145","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.rmed.2010.03.017_bib146","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (MTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5852","key":"10.1016\/j.rmed.2010.03.017_bib147","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.1147379","article-title":"Rheb activates MTOR by antagonizing its endogenous inhibitor, FKBP38","volume":"318","author":"Bai","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib148","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2-MTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"DeYoung","year":"2008","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.rmed.2010.03.017_bib149","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"issue":"5882","key":"10.1016\/j.rmed.2010.03.017_bib150","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to MTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.rmed.2010.03.017_bib151","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of MTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"5712","key":"10.1016\/j.rmed.2010.03.017_bib152","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-MTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib153","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ceb.2008.12.013","article-title":"Tubers and tumors: rapamycin therapy for benign and malignant tumors","volume":"21","author":"Plas","year":"2009","journal-title":"Curr Opin Cell Biol"},{"issue":"6548","key":"10.1016\/j.rmed.2010.03.017_bib154","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70 s6 kinase by kinase activity of FRAP in vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2010.03.017_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2009.02.009","article-title":"Phosphatidic acid signaling to MTOR: Signals for the survival of human cancer cells","author":"Foster","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.rmed.2010.03.017_bib156","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/MCB.00782-08","article-title":"Regulation of MTORC1 and MTORC2 complex assembly by phosphatidic acid: competition with rapamycin","volume":"29","author":"Toschi","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib157","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3835(00)00612-1","article-title":"Overexpression of phospholipase D1 in human breast cancer tissues","volume":"161","author":"Noh","year":"2000","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib158","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/bbrc.2000.3719","article-title":"Increased activity and intranuclear expression of phospholipase D2 in human renal cancer","volume":"278","author":"Zhao","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"1B","key":"10.1016\/j.rmed.2010.03.017_bib159","first-page":"671","article-title":"Phospholipase D activity in human gastric carcinoma","volume":"19","author":"Uchida","year":"1999","journal-title":"Anticancer Res"},{"issue":"5548","key":"10.1016\/j.rmed.2010.03.017_bib160","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of MTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.rmed.2010.03.017_bib161","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.rmed.2010.03.017_bib162","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.rmed.2010.03.017_bib163","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:59:16Z","timestamp":1760612356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611110001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":163,"alternative-id":["S0954611110001356"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.03.017","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphangioleiomyomatosis (LAM): Molecular insights lead to targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}